000 | 01140 a2200373 4500 | ||
---|---|---|---|
005 | 20250512221031.0 | ||
264 | 0 | _c19840314 | |
008 | 198403s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.34.2.198 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWard, C D | |
245 | 0 | 0 |
_aL-dopa decarboxylation in chronically treated patients. _h[electronic resource] |
260 |
_bNeurology _cFeb 1984 |
||
300 |
_a198-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCarbidopa _xtherapeutic use |
650 | 0 | 4 | _aChemistry, Organic |
650 | 0 | 4 | _aDecarboxylation |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aOrganic Chemistry Phenomena |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aTrombley, I K | |
700 | 1 | _aCalne, D B | |
700 | 1 | _aKopin, I J | |
773 | 0 |
_tNeurology _gvol. 34 _gno. 2 _gp. 198-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.34.2.198 _zAvailable from publisher's website |
999 |
_c6537879 _d6537879 |